Biliary duct cancer non-invasive marker based on relative abundance of intestinal microorganisms, screening method and application
A technology of intestinal microbes and relative abundance, applied in the field of non-invasive markers of cholangiocarcinoma, can solve the problem of lack of effective non-invasive diagnostic markers of cholangiocarcinoma, and achieve the effect of improving the accuracy of early diagnosis
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0027] Specific implementation of the present invention, for example Figure 1-6 As shown, 33 feces samples of 33 and non-cancer 47 subjects were collected, and 16S rRNA gene was tested for 16S rRNA gene. Investigation records of demographics baseline data, including age, gender, weight, height, smoking and drinking habits, etc., trace serum tumor markers, liver function indicators. In clinical variables, gender, smoking and drinking habits, cirrhosis and HBV infection, comparable between CCA and CF.
[0028] DNA extraction and 16S rRNA sequencing:
[0029] First, use E.z.n.a. StoolDnakit (D4015, Omega, Inc., USA) extracts the bacterial genome. Amplifies the V3-V4 region of the prokaryic (bacteria and ancient bacteria) subunit (16S) rRNA gene. During the entire DNA extraction, ultrapure water is used to exclude the likelihood of false positive polymerase chain reaction as a negative control. The polymerase chain reaction product was purified with Ampure XT BEADS (Beckman Coulter G...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com